Posts Tagged ‘EndeavorRx’
Digital therapeutics pioneer Akili Interactive Labs goes public, raising $150M+; trades down 49% first day
Akili Interactive is the latest company to go public via SPAC deal (Boston Business Journal): Boston’s Akili Interactive Labs Inc. is the latest Massachusetts-based company to go public after completing a reverse merger — in a year of market turmoil that saw few local firms passing the threshold between private and public status. Shares of…
Read MoreDigital therapeutics pioneer Akili Interactive plans to go public in mid-2022 at a $1B valuation
Palihapitiya-Led SPAC to Merge With Akili in $1 Billion Deal (Bloomberg): Akili Interactive, a startup that has developed a video game to help treat attention-deficit disorders in kids, has agreed to go public through a merger with one of Chamath Palihapitiya’s blank-check companies. The deal, which confirms a Bloomberg News report, values the combined entity…
Read MoreAkili Interactive Labs raises $160M in equity and debt to transform cognitive healthcare via prescription videogame treatments
Akili raises $110m to build its digital therapeutics pipeline (pharmaforum): EndeavorRx became the first and so far only approved prescription video game treatment in the US when it was cleared by the FDA last year to treat attention-deficit hyperactivity disorder (ADHD), and has also been given a green light in Europe.
Read MoreFDA clears first videogame to be prescribed to kids with ADHD: EndeavorRx by Akili Interactive Labs
In a landmark decision, FDA greenlights a video game for kids with ADHD (STAT): The Food and Drug Administration on Monday for the first time gave a green light to a game-based therapeutic: a video game meant to be prescribed to kids with ADHD. The game, known as EndeavorRx and developed by Boston-based Akili Interactive Labs,…
Read More